BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37005458)

  • 1. Acceptance and willingness-to-pay for oocyte cryopreservation in medical versus age-related fertility preservation scenarios among Swedish female university students.
    Gambadauro P; Bränn E; Hadlaczky G
    Sci Rep; 2023 Apr; 13(1):5325. PubMed ID: 37005458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the knowledge, attitudes, and perceptions of women of reproductive age towards fertility and elective oocyte cryopreservation for age-related fertility decline in the UK: a cross-sectional survey.
    Kasaven LS; Mitra A; Ostrysz P; Theodorou E; Murugesu S; Yazbek J; Bracewell-Milnes T; Ben Nagi J; Jones BP; Saso S
    Hum Reprod; 2023 Dec; 38(12):2478-2488. PubMed ID: 37816663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oocyte cryopreservation review: outcomes of medical oocyte cryopreservation and planned oocyte cryopreservation.
    Walker Z; Lanes A; Ginsburg E
    Reprod Biol Endocrinol; 2022 Jan; 20(1):10. PubMed ID: 34996479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic oocyte cryopreservation: national comparison of fertility preservation between women with and without cancer.
    Kawwass JF; Shandley LM; Boulet SL; Hipp HS
    J Assist Reprod Genet; 2020 Apr; 37(4):883-890. PubMed ID: 32062803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Awareness of fertility and reproductive aging in women seeking oocyte cryopreservation, reproductive aged controls, and female health care professionals: A comparative study.
    Dundar Akın O; Boza A; Yakin K; Urman B
    Eur J Obstet Gynecol Reprod Biol; 2019 Feb; 233():146-150. PubMed ID: 30597339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A major increase in oocyte cryopreservation cycles in the USA, Australia and New Zealand since 2010 is highlighted by younger women but a need for standardized data collection.
    Johnston M; Richings NM; Leung A; Sakkas D; Catt S
    Hum Reprod; 2021 Feb; 36(3):624-635. PubMed ID: 33367704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding social oocyte freezing in Italy: a scoping survey on university female students' awareness and attitudes.
    Tozzo P; Fassina A; Nespeca P; Spigarolo G; Caenazzo L
    Life Sci Soc Policy; 2019 May; 15(1):3. PubMed ID: 31049743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproductive experiences of women who cryopreserved oocytes for non-medical reasons.
    Hammarberg K; Kirkman M; Pritchard N; Hickey M; Peate M; McBain J; Agresta F; Bayly C; Fisher J
    Hum Reprod; 2017 Mar; 32(3):575-581. PubMed ID: 28077428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of women and girls undergoing fertility preservation due to oncologic and non-oncologic indications in Sweden-Trends in patients' choices and benefit of the chosen methods after long-term follow up.
    Rodriguez-Wallberg KA; Marklund A; Lundberg F; Wikander I; Milenkovic M; Anastacio A; Sergouniotis F; Wånggren K; Ekengren J; Lind T; Borgström B
    Acta Obstet Gynecol Scand; 2019 May; 98(5):604-615. PubMed ID: 30723910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.
    Martinez F
    Hum Reprod; 2017 Sep; 32(9):1802-1811. PubMed ID: 29117320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postponing Childbearing and Fertility Preservation in Young Professional Women.
    Hurley EG; Ressler IB; Young S; Batcheller A; Thomas MA; DiPaola KB; Rios J
    South Med J; 2018 Apr; 111(4):187-191. PubMed ID: 29719026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decision making processes of women who seek elective oocyte cryopreservation.
    Kim R; Yoon TK; Kang IS; Koong MK; Kim YS; Kim MJ; Lee Y; Kim J
    J Assist Reprod Genet; 2018 Sep; 35(9):1623-1630. PubMed ID: 30006788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Survey of Women Who Cryopreserved Oocytes for Non-medical Indications (Social Fertility Preservation).
    Seyhan A; Akin OD; Ertaş S; Ata B; Yakin K; Urman B
    Reprod Sci; 2021 Aug; 28(8):2216-2222. PubMed ID: 33449346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling of live-birth rates and cost-effectiveness of oocyte cryopreservation for cancer patients prior to high- and low-risk gonadotoxic chemotherapy.
    Lyttle Schumacher B; Grover N; Mesen T; Steiner A; Mersereau J
    Hum Reprod; 2017 Oct; 32(10):2049-2055. PubMed ID: 28938728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public support in the United States for elective oocyte cryopreservation.
    Lewis EI; Missmer SA; Farland LV; Ginsburg ES
    Fertil Steril; 2016 Oct; 106(5):1183-1189. PubMed ID: 27473351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based outcomes after oocyte cryopreservation for donor oocyte in vitro fertilization and planned oocyte cryopreservation: a guideline.
    Practice Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org
    Fertil Steril; 2021 Jul; 116(1):36-47. PubMed ID: 34148587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study.
    Marklund A; Eloranta S; Wikander I; Kitlinski ML; Lood M; Nedstrand E; Thurin-Kjellberg A; Zhang P; Bergh J; Rodriguez-Wallberg KA
    Hum Reprod; 2020 Apr; 35(4):929-938. PubMed ID: 32313940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Awareness, intentions and attitudes towards planned oocyte cryopreservation among female medical staff.
    Kim SM; Choi JY; Rhee MR; Hong SH; Ji IW; Jeong EH; Lee JR
    Reprod Biomed Online; 2022 Jun; 44(6):1169-1176. PubMed ID: 35232673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
    Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
    Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge and beliefs about oocyte cryopreservation for medical and social reasons in female students: a cross-sectional survey.
    Akhondi MM; Ardakani ZB; Warmelink JC; Haghani S; Ranjbar F
    BMC Womens Health; 2023 Jun; 23(1):336. PubMed ID: 37355576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.